Lockheed Martin has returned to invest in Main Sequence Ventures’ second fundraise having previously committed to its Csiro-mandated first fund.
Month: April 2021
Scivita Medical selects corporates for series A
Lilly Asia Ventures co-led a $61.7m round for the endoscopy technology developer that was also backed by Medtronic.
Saint-Gobain gravitates to Richland Capital
Saint-Gobain has contributed to Richland Capital’s third fund, joining fellow corporate investors Asahi Kasei and Solvay.
Daily Deal Round Up: April 27, 2021
Renal care provider InterWell Health and skincare product manufacturer Make Essence both raised approximately $46m while Salesforce-backed JazzHR agreed a merger.
Subsector: AR & VR
Apple last week introduced AirTag, “a small and elegantly designed accessory that helps keep track of and find the items that matter most with Apple’s Find My app”.
Rising Stars Q&A – Greg Hoffman, DuPont Electronics & Imaging Ventures
Q&A with Gregory Aaron Hoffman, DuPont Electronics & Imaging Ventures
Tencent takes $225m to ShareChat
European affiliates of Tencent provided nearly half of the $502m secured by the social network operator at a $2.1bn valuation earlier this month.
Urban Company builds $188m series F round
Prosus has led the on-demand home services provider’s latest round, which was reportedly secured at a $2bn valuation, pushing its total funding past $370m.
Crusoe cruises to $128m series B
Exor, Coinbase Ventures and DRW Venture Capital have all invested in Crusoe Energy Systems, which owns a network of flared gas-powered data centres.
TScan examines $100m IPO possibilities
The Alphabet, Astellas, Novartis and WuXi AppTec-backed T-cell cancer therapy developer has filed to list on the Nasdaq Global Market.
Hello tells of IPO intentions
Ant Group is the largest shareholder in the China-headquartered mobility services provider, which has chosen the US for its initial public offering.
Vera Therapeutics vies for public markets spot
Alphabet and Merck Group could exit the immunological and inflammatory disease therapy developer in an offering with an $86.3m placeholder target.
Carlyle to capture Unchained Labs for $435m
Carlyle Group has agreed to pay $435m for the biologics research technology provider, which has raised $86m from investors including Novo.
Trinomab tracks series A funding
China Medical System and a WuXi Biologics industry investment fund were among the participants in the antibody therapy developer’s $69.3m series A round.